Dishman Carbogen Amcis Limited announces CARBOGEN AMCIS AG's 1,200 kWp solar power plant launch, underscoring commitment to sustainability.
Jagsonpal Pharmaceuticals to acquire 85% stake in Aequitas Healthcare, marking strategic entry into hospital segment.
Ajanta Pharma Limited (NSE: AJANTPHARM) stock has cleared its 6-month resistance trendline, gaining 5% intraday to ₹3352.0.
Vijaya Diagnostic Centre Limited (NSE: VIJAYA) drops 5% intraday to ₹1294.0, with the stock still in breakdown trendline status..
Strides Pharma Science Limited (STAR) partners with Ascent Capital to unlock value in Pivot Path, realizing ₹1,000m while retaining 20% stake.
Alembic Pharmaceuticals Limited (APLLTD) announces USFDA final approval for Dapsone Gel, 5%, expanding its generic drug portfolio.
Indoco Remedies Ltd. announces successful Malta Medicines Authority audit for Goa plant, securing EU GMP certification.
Alembic Pharmaceuticals Limited (APLLTD) announced USFDA final approval for Oseltamivir Phosphate Oral Suspension, 6 mg/mL, expanding its generic drug portfo.
Lupin Limited (LUPIN) secures tentative approval from U.S. FDA for Enzalutamide Tablets, expanding dosage options.
Jagsonpal Pharmaceuticals Limited (JAGSNPHARM) announces the appointment of industry veteran Anil Kumar Matai as an Independent Director, effective June 25.